Clinical Trial Update: AM-101 in the Treatment of Post-Acute Tinnitus 2 [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for AM-101 in the treatment of post-acute tinnitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tinnitus

Drugs mentioned

• AM 101

Snippet

Sponsor: Auris Medical AG | Conditions: Tinnitus | Phase 3 | Status: COMPLETED